PHASE II and biomarker study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma patients Meeting Abstract
| Authors: | Reardon, D.; Molinaro, A.; Peters, K.; Clarke, J.; Jordan, J.; de Groot, J.; Nghiemphu, P.; Kaley, T.; Colman, H.; McCluskey, C.; Smith, T.; Cote, D.; Severgnini, M.; Yearley, J.; Zhao, Q.; Blumenschein, W.; Duda, G.; Muzikansky, A.; Jain, R.; Wen, P.; Nayak, L. |
| Abstract Title: | PHASE II and biomarker study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma patients |
| Meeting Title: | 25th Virtual Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2020 Nov 19-21 |
| Meeting Location: | Virtual Conference |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | ii40 |
| Language: | English |
| ACCESSION: | WOS:000590061300167 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noaa215.166 |
| Notes: | Meeting Abstract: CTIM-32 -- Source: Wos |
